Calmark's distributor in India also signs agreements for the Neo products
Calmark Sweden AB announced today that an exclusive distributor agreement has been signed with r2 Diagnostics in India regarding Calmark's test for newborns.As previously announced, Calmark has entered an exclusive distributor agreement with the company r2 Diagnostics regarding marketing and sales of Calmark's COVID19-LDH test in India. This is now being expanded with the Neo products where the first to be launched is Neo-Bilirubin. Every year, about 25 million children are born in India. Of these, it is estimated that about 30% need to take at least one blood sample to ensure bilirubin